High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin |(Mylotarg®) treatment in acute myeloid leukemia patients

  1. van der Velden, V.H.J.
  2. Boeckx, N.
  3. Jedema, I.
  4. te Marvelde, J.G.
  5. Hoogeveen, P.G.
  6. Boogaerts, M.
  7. van Dongen, J.J.M.
Journal:
Leukemia

ISSN: 0887-6924

Year of publication: 2004

Volume: 18

Issue: 5

Pages: 983-988

Type: Article

DOI: 10.1038/SJ.LEU.2403350 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus